Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 106Neoplasm Metastasis 9Ovarian Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Breast Neoplasms, Male 3Prostatic Neoplasms 2Obesity 2Carcinoma, Non-Small-Cell Lung 2Breast Diseases 2Breast Carcinoma In Situ 2Breast Cancer Metastatic 2Arthralgia 2Triple Negative Breast Neoplasms 1Sexuality 1Sexual Dysfunctions, Psychological 1Recurrence 1Primary Breast Cancer ER+ve 1Premenopausal Breast Cancer 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1Pain 1Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer 1Multiple Endocrine Neoplasia Type 1 1Metastatic Beast Cancer 1Locoregional Recurrence 1Hyperglycemia 1Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Hormone Receptor Positive Malignant Neoplasm of Breast 1HR Positive HER2 Negative Advanced Breast Cancer 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × exemestane × Clear all
NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

First Hospital of China Medical University

Unknown
1,354 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡